A new perspective published in the *Journal of the American College of Cardiology* by researchers from Weill Cornell Medicine, NewYork-Presbyterian, and Yale School of Medicine emphasizes the need for earlier and more aggressive treatment of high cholesterol. The 2026 guidelines from the American College of Cardiology and the American Heart Association aim to prevent heart disease, which remains the leading cause of death in the United States. The guidelines encourage doctors to identify cardiovascular risks earlier and to consider additional risk factors beyond standard cholesterol tests, such as lipoprotein(a) levels and coronary artery calcium scans. Dr. Madeline R. Sterling, the lead author, highlights the role of primary care clinicians in managing dyslipidemia and promoting healthy lifestyle changes. However, the implementation of these recommendations may be challenging due to time constraints during patient visits and potential disparities in access to advanced testing. The authors stress the importance of collaboration among healthcare providers and the need for improved insurance coverage and patient education to ensure these guidelines are effectively put into practice.